---
module: 087-03
language: en
chapter: 87
title: "Biomolecules, Protein Structure, Enzymes, Cofactors, and Biochemical Regulation"
module_title: "Cofactors, biochemical regulation, pathway control, and molecular measurement"
source_sha256: 35b2e75c47aeb46e7e96f1b26e26e3e368717ba777da5d46f0711afab2198e9d
---
# Cofactors, regulation, pathway control, and measurement

## Vitamin-derived cofactors
### Deficiency impairs enzymes sharing a task
### Excess adds little once enzymes saturate
#### Stored fat-soluble vitamins can be toxic
### Status depends on absorption through clearance

## B vitamins in energy metabolism
### Thiamine pyrophosphate
#### Oxidative decarboxylation, transketolase
#### Brain and heart; lactic acidosis
### Riboflavin forms flavins
#### Yellow urine mainly reflects excretion
### Niacin forms NAD and NADP
#### NAD catabolic, NADP biosynthetic
#### Skin, gut, nervous system
### Pantothenate: coenzyme A and thioesters
### Pyridoxal phosphate and amino-group transfer
#### Neuropathy, seizures, sideroblastic anaemia

## Carriers of carbon and one-carbon units
### Biotin carries activated carbon dioxide
#### Avidin binding, immunoassay interference
### Folate carries one-carbon units
### B12: methionine synthase and mutase
#### Folate trap causes megaloblastic change
#### Folate fixes anaemia, not nerve damage

## Other vitamins and metals
### Vitamin C: hydroxylases and non-haem iron
### Vitamin K: gamma-carboxylation, warfarin
### Vitamins A and D act via nuclear receptors
### Magnesium, zinc, iron, copper, selenium, others
### Free transition metals drive harmful redox

## Mechanisms of regulation
### Substrate availability sets flux
#### Saturating in-vitro assays can miss defects
### Allosteric effectors report cell state
#### Feedback inhibition of committed step
#### Feed-forward activation
#### Reciprocal regulation prevents waste
### Covalent modification by kinases, phosphatases
#### Phosphorylation has no universal meaning
### Proteolysis: activation and removal
#### Synthesis and degradation set abundance

## Compartments, hormones, and control
### Compartments separate competing pathways
#### Cytosolic and mitochondrial NAD pools
### Insulin stores; glucagon, catecholamines mobilise
### Longer-term hormones change capacity
### Metabolic control is distributed
#### Slowest step not automatically rate-limiting
#### Control shifts with feeding, exercise, disease
### Energy charge and redox ratios
#### Hard to infer from plasma

## Assay principles
### Direct measurement or coupled inference
### Spectrophotometry and Beer-Lambert relation
### Mass spectrometry is highly specific
### Immunoassays: competitive or sandwich
#### Cross-reaction, heterophiles, hook, biotin
#### Precise yet systematically wrong
### Accuracy versus precision
### Detection limits versus clinical sensitivity
### Calibration and traceability

## Interpreting results
### Pre-analytical variation exceeds instrument error
#### Haemolysis raises potassium, lactate dehydrogenase
#### Ongoing metabolism consumes glucose
### Reference intervals are not treatment thresholds
#### Healthy people fall outside by chance
### Dynamic tests probe regulation
#### Normal baseline, abnormal response
### Omics reveal patterns and hypotheses
#### Multiple testing, batch effects, validation
### Specify reaction, compartment, time, assay
